Pharmacokinetics of transfer of piperaquine into the breast milk of Melanesian mothers
Journal Title
Antimicrobial Agents and Chemotherapy
Publication Type
Journal Article in press
Abstract
Transfer of piperaquine (PQ) into breast milk was examined in 27 Papua New Guinean women given a three-day course of dihydroartemisinin-PQ or sulfadoxine-pyrimethamine-PQ during the second/third trimester. Breast milk was sampled on Days 1, 2, 3-5, 7-11 and 14-17 post-delivery, a median (range) of 70 (6-145) days post-dose. A blood sample was taken at delivery and additional serial samples were available in 9 women who delivered within 42 days of dosing. Milk and plasma PQ was assayed by high performance liquid chromatography. A population-based approach was used to model loge(plasma) and milk concentration-time data. A sigmoid Emax model best described PQ breast milk transfer. The population average milk:plasma PQ ratio was 0.58 with a peak of 2.5 at delivery. The model-derived maximum milk intake (148 mL/kg/day) was similar to the accepted value of 150 mL/kg/day. The median estimated absolute and relative cumulative infant PQ doses were 22 mug and 0.07%, respectively, corresponding to absolute and relative daily doses of 0.41mug/kg and 0.004%. Model-based simulations for PQ treatment regimens given at birth, 1 week post-delivery and 6 weeks post-delivery showed that the highest median estimated relative total infant dose (0.36%, or median absolute total dose 101 mug/kg) was seen after maternal PQ treatment 6 weeks postpartum. The maximum simulated relative total and daily dose from any scenario were 4.3% and 2.5%, respectively, lower than the recommended 10% upper limit. Piperaquine is transferred into breast milk after maternal treatment doses but PQ exposure in suckling infants appears safe.
Publisher
ASM
Research Division(s)
Population Health And Immunity
PubMed ID
25963980
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2015-05-22 11:19:38
Last Modified: 2019-04-01 09:01:18
An error has occurred. This application may no longer respond until reloaded. Reload 🗙